我国生物医药产业国际竞争力对策研究

发布时间：2018-01-01 12:16

本文关键词：我国生物医药产业国际竞争力对策研究　出处：《安徽大学》2013年硕士论文　论文类型：学位论文

【摘要】：随着经济全球化的发展,提高产业国际竞争力得到越来越多国家的重视。近年来,生物医药产业迅速发展,在全球医药市场中所占比例逐年提高,我国非常重视生物医药产业发展,在《“十二五”国家战略性新兴产业发展规划》中也把生物产业列入战略性新型产业,而生物医药产业就是生物产业的最大分支。近三十年来国内的政策环境和市场需求有利于生物医药产业的发展,我国的生物医药产业在研发水平、技术水平、生产水平、人力资源等方面取得了令人瞩目的成绩,但是与欧美等发达的生物医药产业水平相比,还是处于初级水平。我国人口众多,生物医药市场很大,但是我国的生物医药企业不止在世界市场上只占2%左右的比重,在国内市场上也并没有较高的市场占有率,我国必须要提升生物医药产业的国际竞争力。本文在产业国际竞争力理论基础之上,分析了我国生物医药产业进出口贸易的情况和国际竞争力现状,继而对影响我国生物医药产业国际竞争力的因素进行研究,提出了提升我国生物医药产业国际竞争力的一些对策建议,期望能促进我国生物医药产业的研发创新能力、产品质量、产品的种类、生物医药制品知识产权保护等方面的一些提高,进而提升我国生物医药产业的国际竞争力。本文的基本框架安排如下：第1章绪论部分。对提升我国生物医药产业国际竞争力的研究背景和意义进行了阐述,之后回顾了我国生物医药产业国际竞争力的研究现状,并对本文的创新点进行了简要的介绍,最后在对生物医药产业的概念进行界定后,详细阐述了生物医药产业的特点。第2章是文章研究的理论基础。本文先阐明了产业国际竞争力的定义和内涵,然后详细阐述了产业国际竞争力的理论基础,最后阐述了产业国际竞争力的理论模型和评价指标。第3章首先分析了国际生物医药市场的基本情况,对各国关于生物医药产业的政策进行了对比分析,然后分析了现阶段我国生物医药产业的特点。第4章在进出口数据的基础上计算了净出口指标、贸易竞争力指数、市场占有率和显示性比较优势指数,通过这些指标可以看出我国的生物医药产业的国际竞争力较低,需要提高。第5章通过建立模型对影响我国生物医药产业国际竞争力的因素进行了分析,包括生产要素、政府、需求条件等决定因素和产品质量、品牌、营销等辅助因素。最后一章在以上各章的基础上,提出了提升我国生物医药产业竞争力的一些对策。本文在产业国际竞争力的理论和方法研究的基础上,对我国生物医药产业国际竞争力状况进行了初步、系统的探索。
[Abstract]:With the development of economic globalization, improve the international competitiveness of the industry to get more and more national attention. In recent years, the rapid development of bio pharmaceutical industry, the proportion increased year by year in the global pharmaceutical market, our country attaches great importance to the development of bio pharmaceutical industry, "in the" 12th Five-Year "national strategic emerging industry development planning in the biotechnology industry in. The strategic new industry, and the largest branch of bio pharmaceutical industry is the biological industry. Over the past thirty years, the domestic policy environment and market demand is conducive to the development of bio pharmaceutical industry, China's bio pharmaceutical industry in the development level, technical level, production level, human resources has made remarkable achievements, but compared to the biological the pharmaceutical industry level and developed, still at the primary level. China has a large population, bio pharmaceutical market is large, but China's bio medicine Pharmaceutical companies not only account for about 2% of the world market share, but also have no high market share in the domestic market. China must enhance the international competitiveness of the bio pharmaceutical industry.
Based on the theory of industrial international competitiveness, analyzes the situation and the international competitiveness of China's bio pharmaceutical industry, import and export trade, and to study the factors affecting the international competitiveness of China's bio pharmaceutical industry, and puts forward some countermeasures to enhance the international competitiveness of China's bio pharmaceutical industry in China, I hope to promote the bio pharmaceutical industry the research and innovation capacity, product quality, product variety, improve biomedical products, the protection of intellectual property rights, and enhance the international competitiveness of China's bio pharmaceutical industry. The basic frame of the paper is as follows:
The first chapter is the introduction part. To enhance the international competitiveness of China's bio pharmaceutical industry research background and significance are expounded, then reviews the research status of the international competitiveness of China's bio pharmaceutical industry, and the innovation of this paper is briefly introduced, finally defines the concept of biological medicine industry, described in detail the characteristics of bio pharmaceutical industry.
The second chapter is the theoretical basis of the article research. First, it clarifies the definition and connotation of the international competitiveness of the industry, then elaborates the theoretical basis of the international competitiveness of the industry, and finally expounds the theoretical model and evaluation index of the international competitiveness of the industry.
The third chapter first analyzes the basic situation of the international bio pharmaceutical market, compares the policies of various countries on biomedicine industry, and then analyzes the characteristics of China's bio pharmaceutical industry at this stage.
The fourth chapter, based on the data of import and export, calculates net export index, trade competitiveness index, market share and revealed comparative advantage index. Through these indicators, we can see that the international competitiveness of China's bio pharmaceutical industry is low and needs to be improved.
The fifth chapter analyzes the factors that influence the competitiveness of China's biopharmaceutical industry by establishing models, including factors of production, government, demand and other factors, including product quality, brand, marketing and other auxiliary factors.
On the basis of the above chapters, the last chapter puts forward some countermeasures to improve the competitiveness of China's bio pharmaceutical industry.
On the basis of the research on the theory and method of the international competitiveness of the industry, this paper has carried out a preliminary and systematic exploration of the international competitiveness of China's bio pharmaceutical industry.

【学位授予单位】：安徽大学
【学位级别】：硕士
【学位授予年份】：2013
【分类号】：F426.72;F752.6

【参考文献】